SciVision Biotech Inc (1786) — Capital Reinvestment Ratio
SciVision Biotech Inc (1786) has a Capital Reinvestment Ratio of 0.20x as of March 2026, meaning it reinvests 0% of its operating cash flow (NT$48.51 Million) in capital expenditures (NT$9.60 Million). Check SciVision Biotech Inc (1786) tangible net worth to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
SciVision Biotech Inc Capital Reinvestment Ratio (2010–2025)
This chart tracks SciVision Biotech Inc's Capital Reinvestment Ratio across 16 annual periods. For the full cash flow conversion analysis, see cash flow conversion of SciVision Biotech Inc.
Annual Capital Reinvestment Ratio for SciVision Biotech Inc (2010–2025)
Year-by-year Capital Reinvestment Ratio for SciVision Biotech Inc from 2010 to 2025. See SciVision Biotech Inc free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (TWD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.82x | NT$123.99 Million | NT$101.53 Million | ▲ +533.5% |
| 2024 | 0.13x | NT$269.87 Million | NT$34.88 Million | ▲ +136.8% |
| 2023 | 0.05x | NT$272.01 Million | NT$14.84 Million | ▼ -35.0% |
| 2022 | 0.08x | NT$178.21 Million | NT$14.96 Million | ▼ -67.9% |
| 2021 | 0.26x | NT$98.51 Million | NT$25.77 Million | ▼ -50.5% |
| 2020 | 0.53x | NT$126.47 Million | NT$66.84 Million | ▼ -46.5% |
| 2019 | 0.99x | NT$204.40 Million | NT$202.03 Million | ▲ +15.8% |
| 2018 | 0.85x | NT$111.70 Million | NT$95.32 Million | ▼ -95.8% |
| 2017 | 20.29x | NT$15.98 Million | NT$324.26 Million | ▲ +237.3% |
| 2016 | 6.02x | NT$38.29 Million | NT$230.32 Million | ▲ +46.0% |
| 2015 | 4.12x | NT$49.81 Million | NT$205.27 Million | ▼ -94.0% |
| 2014 | 68.18x | NT$1.85 Million | NT$126.27 Million | ▲ +9062.9% |
| 2013 | 0.74x | NT$37.27 Million | NT$27.74 Million | ▲ +182.3% |
| 2012 | 0.26x | NT$51.52 Million | NT$13.58 Million | ▼ -53.2% |
| 2011 | 0.56x | NT$37.13 Million | NT$20.91 Million | ▼ -83.3% |
| 2010 | 3.38x | NT$6.85 Million | NT$23.13 Million | — |